title: Left atrial appendage occlusion addresses the tremendous unmet needs of stroke prevention in atrial fibrillation that persist despite recent advances in anticoagulation therapy.
authors.affiliation: From the Intermountain Medical Center, Salt Lake City, UT (B.W., T.J.B.); and Cedars Sinai Medical Center, Los Angeles, CA (S.K.). brian.whisenant@imail.org.
authors.forename: Brian
authors.initials: B
authors.lastname: Whisenant
authors.affiliation: From the Intermountain Medical Center, Salt Lake City, UT (B.W., T.J.B.); and Cedars Sinai Medical Center, Los Angeles, CA (S.K.).
authors.forename: Saibal
authors.initials: S
authors.lastname: Kar
authors.affiliation: From the Intermountain Medical Center, Salt Lake City, UT (B.W., T.J.B.); and Cedars Sinai Medical Center, Los Angeles, CA (S.K.).
authors.forename: T Jared
authors.initials: TJ
authors.lastname: Bunch
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D020517:Atrial Appendage / Q000601:surgery*; D001281:Atrial Fibrillation; D006801:Humans; D055989:Septal Occluder Device; D020521:Stroke / Q000209:etiology*
chemical_list: D000925:Anticoagulants